Paul G. Marshall
Corporate Officer/Principal chez The American Society for Cell Biology
Profil
Paul G.
Marshall is a member of The American Society for Cell Biology and the International Society for Pharmaceutical Engineering.
He previously worked as a Director at Medicago, Inc., Senior Vice President-Technical Operations at Heron Therapeutics, Inc., Vice President-Corporate Manufacturing at Amgen, Inc., Vice President-Manufacturing & Supply Operations at Amylin Pharmaceuticals, Inc., and President-Manufacturing at Baxter International, Inc. He also served as Head-Operations at Creative Biomolecules, Inc. Marshall holds graduate and undergraduate degrees from Brown University and the University of Massachusetts.
Currently, he holds positions at The American Society for Cell Biology and the International Society for Pharmaceutical Engineering.
Postes actifs de Paul G. Marshall
| Sociétés | Poste | Début |
|---|---|---|
| The American Society for Cell Biology | Corporate Officer/Principal | - |
International Society for Pharmaceutical Engineering
 International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Corporate Officer/Principal | - |
Anciens postes connus de Paul G. Marshall
| Sociétés | Poste | Fin |
|---|---|---|
| HERON THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 30/09/2016 |
Medicago, Inc.
 Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Director/Board Member | 27/11/2008 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/2005 |
Creative Biomolecules, Inc.
 Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Formation de Paul G. Marshall
| Brown University | Graduate Degree |
| University of Massachusetts | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
Creative Biomolecules, Inc.
Creative Biomolecules, Inc. BiotechnologyHealth Technology Creative Biomolecules, Inc. develops products for human tissue regeneration and organs based on morphogenic proteins. The company was founded by Roberto Crea, Fred Bernard Craves and Charles Cohen and is headquartered in Hopkinton, MA. | Health Technology |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |
| The American Society for Cell Biology | |
International Society for Pharmaceutical Engineering
International Society for Pharmaceutical Engineering Miscellaneous Commercial ServicesCommercial Services The International Society for Pharmaceutical Engineering is a nonprofit association that focuses on scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle. The non-profit company is based in Tampa, FL. The company engages with all levels of regulators to ensure that their education, training, document development, and interpretation are cutting-edge and focused on enabling the production and supply of therapies and devices with unmatched levels of flow, efficiency, and quality sustainably and at scale. John Bournas has been the CEO of the company since 2015. | Commercial Services |
